levofloxacin has been researched along with Long QT Syndrome in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.35) | 18.2507 |
2000's | 7 (30.43) | 29.6817 |
2010's | 10 (43.48) | 24.3611 |
2020's | 5 (21.74) | 2.80 |
Authors | Studies |
---|---|
Gao, J; Gao, M; Li, L; Liu, F; Liu, Y; Pang, Y; Shu, W; Sun, Y; Xie, L; Zhang, L | 1 |
Fu, A; Gao, A; Guo, D; Guo, H; Li, C; Li, P; Lu, J; Zhao, P | 1 |
Cole, ST; Djumanov, D; Ferber, G; Fernandes, S; Prasad, K; Rosano, G; Sugiyama, A; Täubel, J; Van Langenhoven, L; Wibberley, H | 1 |
Khajavian, S; Moradi, F; Rajabian, M; Ruzbahani, M; Shahbazi, F; Shahsavari, S; Shojaei, L; Tamasoki, N | 1 |
Akbulut Koyuncu, İM; Kızıltunç, E; Uğurlu Ilgın, B | 1 |
Groo, VL; Sadr, R; Tilton, JJ | 1 |
Chen, JC; Kuo, CW; Lin, CC; Tsai, LH; Weng, YM | 1 |
Bennett, CL; Jacob, S; Li, M; Lu, ZK; Rao, GA; Sutton, SS; Yuan, J | 1 |
Diehl, NN; Getz, TW; Heckman, MG; Mentel, JJ; Pagan, RJ; Palmer, WC; Racho, RG; Ray, JC; Sears, SP; Seeger, KM; Serra-Valentin, NA; Snipelisky, DF; Stancampiano, FF | 1 |
Al-Zaiti, SS; Carey, MG; Kozik, TM; Pelter, MM | 1 |
Birkhoff, W; Burggraaf, J; Danhof, M; Gotta, V; Kamerling, I; Kervezee, L; Meijer, JH; Stevens, J | 1 |
Garnett, C; Johannesen, L | 1 |
Ferber, G; Fernandes, S; Täubel, J | 1 |
Foulon, V; Spriet, I; Vandael, E; Vandenberghe, J; Vandenberk, B; Willems, R | 1 |
Estes, LL; Wilson, JW; Zeuli, JD | 1 |
Chien, S; Goodman, DB; Natarajan, J; Noel, GJ; Padmanabhan, M; Solanki, B | 1 |
Blackmon, CL; Nykamp, DL; Roberson, AG; Schmidt, PE | 1 |
Byrns, K; Goldner, B; Makaryus, AN; Makaryus, MN; Natarajan, U; Singer, C | 1 |
Cox, CD; Meyerrose, GE; Peeters, MJ; Seifert, CF; Tsikouris, JP | 1 |
Kawai, H; Komiya, M; Matsumoto, T; Nakayasu, T; Shimada, J; Yamaguchi, H; Yokoyama, H | 1 |
Samaha, FF | 1 |
Chiba, K; Hashimoto, K; Satoh, Y; Shiina, H; Sugiyama, A | 1 |
2 review(s) available for levofloxacin and Long QT Syndrome
Article | Year |
---|---|
Cardiac risks associated with antibiotics: azithromycin and levofloxacin.
Topics: Anti-Bacterial Agents; Azithromycin; Death; Humans; Levofloxacin; Long QT Syndrome | 2015 |
Commentary on: "Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug Administration".
Topics: Animals; Arrhythmias, Cardiac; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Levofloxacin; Long QT Syndrome | 2016 |
3 trial(s) available for levofloxacin and Long QT Syndrome
Article | Year |
---|---|
Effects of the Fluoroquinolones Moxifloxacin and Levofloxacin on the QT Subintervals: Sex Differences in Ventricular Repolarization.
Topics: Action Potentials; Adult; Algorithms; Anti-Bacterial Agents; Calcium Channels; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Gonadal Steroid Hormones; Healthy Volunteers; Heart; Humans; Levofloxacin; Long QT Syndrome; Male; Moxifloxacin; Potassium Channels; Retrospective Studies; Sex Characteristics | 2020 |
Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
Topics: Administration, Oral; Adult; Aged; Area Under Curve; Cross-Over Studies; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heart Conduction System; Heart Rate; Humans; Levofloxacin; Linear Models; Long QT Syndrome; Male; Middle Aged; Myocardial Contraction; Ofloxacin; Syncope; Tachycardia; Time Factors | 2004 |
Effects of three fluoroquinolones on QT analysis after standard treatment courses.
Topics: Analysis of Variance; Aza Compounds; Ciprofloxacin; Cross-Over Studies; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Levofloxacin; Long QT Syndrome; Male; Moxifloxacin; Ofloxacin; Quinolines; Statistics, Nonparametric; Torsades de Pointes | 2006 |
18 other study(ies) available for levofloxacin and Long QT Syndrome
Article | Year |
---|---|
Development and Validation of a Nomogram for Prediction of QT Interval Prolongation in Patients Administered Bedaquiline-Containing Regimens in China: a Modeling Study.
Topics: Antitubercular Agents; Clofazimine; Creatinine; Diarylquinolines; Humans; Levofloxacin; Long QT Syndrome; Moxifloxacin; Nomograms; Tuberculosis, Multidrug-Resistant | 2022 |
Analysis of clinical characteristics and automatic monitoring of drug-induced arrhythmias in 167,546 inpatients.
Topics: Aged; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Inpatients; Levofloxacin; Long QT Syndrome; Male; Retrospective Studies; Risk Factors | 2023 |
Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia.
Topics: Adult; Aged; Cross-Sectional Studies; Electrocardiography; Female; Humans; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Pneumonia; Torsades de Pointes | 2020 |
Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydroxychloroquine; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Oseltamivir; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Young Adult | 2021 |
Concomitant use of levofloxacin and fluconazole leading to possible torsades de pointes.
Topics: Adult; Electrocardiography; Female; Fluconazole; Humans; Levofloxacin; Long QT Syndrome; Risk Factors; Torsades de Pointes | 2019 |
Risk screening for long QT prior to prescribing levofloxacin.
Topics: Aged; Anti-Bacterial Agents; Contraindications; Electrocardiography; Emergency Service, Hospital; Female; Humans; Levofloxacin; Long QT Syndrome; Pneumonia, Bacterial; Risk Factors; Torsades de Pointes | 2014 |
Rare Incidence of Ventricular Tachycardia and Torsades de Pointes in Hospitalized Patients With Prolonged QT Who Later Received Levofloxacin: A Retrospective Study.
Topics: Aged; Anti-Bacterial Agents; Female; Hospitalization; Humans; Incidence; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Retrospective Studies; Tachycardia, Ventricular; Torsades de Pointes | 2015 |
Drug Induced ECG Abnormalities.
Topics: Anti-Bacterial Agents; Bronchitis; Electrocardiography; Female; Humans; Levofloxacin; Long QT Syndrome; Middle Aged | 2015 |
Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug Administration.
Topics: Administration, Oral; Adult; Circadian Rhythm; Clinical Trials as Topic; Computer Simulation; Cross-Over Studies; Drug Administration Schedule; Electrocardiography; Heart Conduction System; Humans; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Random Allocation; Young Adult | 2016 |
Time of the Day and Magnitude of the Effect of a Drug on the QTc Interval.
Topics: Electrocardiography; Humans; Levofloxacin; Long QT Syndrome | 2017 |
Development of a risk score for QTc-prolongation: the RISQ-PATH study.
Topics: Aged; Female; Fluconazole; Haloperidol; Humans; Levofloxacin; Long QT Syndrome; Male; Models, Statistical; Predictive Value of Tests; Risk Factors; ROC Curve | 2017 |
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole | 2013 |
Moxifloxacin: new preparation. A me-too with more cardiac risks.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Approval; Fluoroquinolones; France; Humans; Levofloxacin; Long QT Syndrome; Ofloxacin; Pneumonia | 2002 |
QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine.
Topics: Anti-Infective Agents, Urinary; Antidepressive Agents; Cytochrome P-450 CYP2D6 Inhibitors; Drug Synergism; Female; Fluoxetine; Humans; Imipramine; Levofloxacin; Long QT Syndrome; Middle Aged; Ofloxacin | 2005 |
Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Levofloxacin; Long QT Syndrome; Male; Ofloxacin; Prognosis; Prospective Studies; Prostatitis; Respiratory Tract Infections; Severity of Illness Index; Urinary Tract Infections | 2006 |
Post-marketing surveillance of the safety of levofloxacin in Japan.
Topics: Achilles Tendon; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemia; Japan; Levofloxacin; Liver Diseases; Long QT Syndrome; Male; Middle Aged; Ofloxacin; Photosensitivity Disorders; Product Surveillance, Postmarketing; Seizures; Torsades de Pointes | 2007 |
QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Electrocardiography; Female; Heart Conduction System; Humans; Levofloxacin; Long QT Syndrome; Ofloxacin; Tachycardia, Ventricular | 1999 |
Proarrhythmic effects of fluoroquinolone antibacterial agents: in vivo effects as physiologic substrate for torsades.
Topics: Action Potentials; Animals; Anti-Infective Agents; Dogs; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Heart; Heart Block; Levofloxacin; Long QT Syndrome; Male; Models, Animal; Ofloxacin; Torsades de Pointes; Ventricular Dysfunction, Right | 2000 |